Understanding and Manipulating G Protein α Subunit and Phospholipase C Signaling Networks

了解和操作 G 蛋白 α 亚基和磷脂酶 C 信号网络

基本信息

  • 批准号:
    10621415
  • 负责人:
  • 金额:
    $ 53.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-05-01 至 2028-05-31
  • 项目状态:
    未结题

项目摘要

My laboratory is interested signal transduction by G protein-coupled receptors (GPCRs) with a specific focus on the second messenger pathways downstream and how they drive physiology and pathophysiology in specific cells and tissues. GPCRs signaling pathways are ubiquitous and conserved, with cellular responses determined by 1) the specific GPCRs and G proteins expressed in the cell and 2) how the cells decode signals generated by these receptors. My career has been focused on uncovering novel cellular signal transduction mechanisms at a cellular and molecular level that move beyond a canonical GPCR paradigm where individual GPCRs simply couple to 3 major signal transduction pathways, phospholipase C activation, adenylyl cyclase regulation, and RhoGEF stimulation, and the cells do the rest. In this renewal application we propose to capitalize on advances made in the previous funding in two general areas 1) Proteomic analysis of G protein α subunit-mediated signal transduction pathways and; 2) intracellular signaling by β-adrenergic receptors (βARs) and phospholipase C in cardiac myocytes. The first project is based on the striking success of our proteomic screens using proximity labeling mass spectrometry that maintains cell context while identifying protein-protein interactions. We propose to characterize two novel G protein targets from these screens that play roles in regulation of chromatin remodeling and gene expression through mechanisms that would be unprecedented downstream of GPCRs. In addition, we propose to leverage this method to identification of new signal pathways mediated by G proteins as GPCRs move through the endocytic and recycling pathways. Intracellular signaling by GPCRs is a new and emerging paradigm in the field but much less is known about intracellular G protein and effector engagement by internal GPCRs. The second direction will be to follow up our finding that phospholipase C activity at the Golgi apparatus is regulated by intracellular Golgi localized β1-adrenergic receptors (β1ARs). The proposed experiments will test the hypothesis that intracellular β1ARs regulate a unique subset of genes in cardiac myocytes related to cardiac hypertrophy through regulation of phosphoinositide hydrolysis at the Golgi apparatus. We will determine what signaling pathways are regulated by Golgi β1ARs beyond the Epac-PLCε- PKD signaling pathway that we have previously described. Finally, we will investigate the mechanisms for pathways downstream of β2ARs that oppose hypertrophic β1AR signaling at the Golgi. This is exciting because β1AR signaling in vivo is pro-hypertrophic while β2AR signaling is protective and will uncover a novel mechanism for protective β2AR signaling. Overall, these experiments will reveal novel signaling mechanisms that have implications for therapies that target GPCRs.
我的实验室对G蛋白偶联受体(GPCRs)的信号转导感兴趣,特别关注 第二信使通路下游,以及它们如何驱动生理学和病理生理学, 细胞和组织。GPCR信号通路是普遍存在的和保守的,细胞反应确定 通过1)细胞中表达的特异性GPCR和G蛋白以及2)细胞如何解码产生的信号 这些受体。我的职业生涯一直专注于发现新的细胞信号转导机制 在细胞和分子水平上,超越了典型的GPCR范式,其中单个GPCR只是 偶联3个主要信号转导途径,磷脂酶C激活,腺苷酸环化酶调节, RhoGEF刺激,细胞做剩下的。在这份续约申请中,我们建议利用预付款 在以往的资助中主要做了两个方面的工作:1)G蛋白α亚基介导信号的蛋白质组学分析 转导途径和; 2)β-肾上腺素能受体(β AR)和磷脂酶C的细胞内信号传导 心肌细胞第一个项目是基于我们的蛋白质组学筛选的惊人成功, 标记质谱,保持细胞环境,同时识别蛋白质-蛋白质相互作用。我们提出 从这些筛选中表征两个在染色质调节中起作用的新G蛋白靶点, 重塑和基因表达的机制,这将是前所未有的下游GPCR。在 此外,我们建议利用这种方法来鉴定由G蛋白介导的新信号通路, GPCR通过内吞和再循环途径移动。通过GPCR的细胞内信号传导是一种新的, 但对细胞内G蛋白和效应子的参与知之甚少, 内部GPCR。第二个方向将是跟进我们的发现,磷脂酶C的活性在高尔基体 细胞器受细胞内高尔基体定位的β1肾上腺素能受体(β1ARs)调节。拟议 实验将检验细胞内β 1AR调节心脏中一个独特的基因子集的假设, 通过调节高尔基体磷酸肌醇水解与心肌肥大相关的心肌细胞 设备.我们将确定高尔基体β 1 AR在Epac-PLCε-受体之外调节哪些信号通路。 PKD信号通路,我们以前已经描述过。最后,我们将研究 β 2 AR下游通路,其对抗高尔基体处的肥大β 1 AR信号传导。这很令人兴奋,因为 体内β 1 AR信号是促肥大的,而β 2 AR信号是保护性的,这将揭示一种新的机制 保护性β2AR信号。总的来说,这些实验将揭示新的信号机制, 对靶向GPCR的治疗的影响。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Stabilization of interdomain interactions in G protein α subunits as a determinant of Gαi subtype signaling specificity.
G 蛋白 α 亚基中域间相互作用的稳定作为 Gαi 亚型信号传导特异性的决定因素。
  • DOI:
    10.1016/j.jbc.2024.107211
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Lefevre,TylerJ;Wei,Wenyuan;Mukhaleva,Elizaveta;MedaVenkata,SaiPranathi;Chandan,NaincyR;Abraham,Saji;Li,Yong;Dessauer,CarmenW;Vaidehi,Nagarajan;Smrcka,AlanV
  • 通讯作者:
    Smrcka,AlanV
Subcellular β-Adrenergic Receptor Signaling in Cardiac Physiology and Disease.
β-arrestin mediates communication between plasma membrane and intracellular GPCRs to regulate signaling.
  • DOI:
    10.1038/s42003-020-01510-2
  • 发表时间:
    2020-12-18
  • 期刊:
  • 影响因子:
    5.9
  • 作者:
    DeNies MS;Smrcka AV;Schnell S;Liu AP
  • 通讯作者:
    Liu AP
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alan V. Smrcka其他文献

Phospholipase C-Epsilon Couples cAMP Production and Epac2 Activation to the Facilitation of Calcium-Induced Calcium Release (CICR) in Pancreatic Beta Cells
  • DOI:
    10.1016/j.bpj.2010.12.3022
  • 发表时间:
    2011-02-02
  • 期刊:
  • 影响因子:
  • 作者:
    George G. Holz;Igor Dzhura;Oleg Chepurny;Colin A. Leech;Elvira Dzhura;Parisa Afshari;Grant G. Kelley;Michael W. Roe;Michael J. Rindler;Xin Xu;Youming Lu;Sundeep Malik;Alan V. Smrcka
  • 通讯作者:
    Alan V. Smrcka
Neuromodulation of voltage-gated sodium channels by Gβ1γ2 subunits: Implications for emGNB1/em-linked encephalopathy
Gβ1γ2 亚基对电压门控钠通道的神经调节:对 emGNB1/em 相关脑病的影响
  • DOI:
    10.1016/j.nbd.2025.106990
  • 发表时间:
    2025-09-01
  • 期刊:
  • 影响因子:
    5.600
  • 作者:
    Nicholas Denomme;Samantha L. Hodges;Luis Lopez-Santiago;Yukun Yuan;Julie M. Ziobro;Joe Minton;Chunling Chen;Yan Chen;Jacob M. Hull;James Offord;Alan V. Smrcka;Lori L. Isom
  • 通讯作者:
    Lori L. Isom
ロイシンによるmTOR活性化機構解明のためのロイシン誘導体とロイシン結合タンパク質との相互作用解析
亮氨酸衍生物与亮氨酸结合蛋白之间的相互作用分析,阐明亮氨酸激活 mTOR 的机制
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nhat-Tu Le*;Yuichiro Takei*;Yuki Izawa-Ishizawa*;Kyung-Sun Heo;Hakjoo Lee;Alan V. Smrcka;Benjamin L. Miller;Kyung Ae Ko;Sara Ture;Craig Morrell;Keigi Fujiwara;Masashi Akaike and Jun-ichi Abe.;奥田 傑
  • 通讯作者:
    奥田 傑
Phospholipase C β2 Association with Phospholipid Interfaces Assessed by Fluorescence Resonance Energy Transfer: G PROTEIN βγ SUBUNIT-MEDIATED TRANSLOCATION IS NOT REQUIRED FOR ENZYME ACTIVATION
  • DOI:
    10.1074/jbc.271.41.25071
  • 发表时间:
    1996-10-11
  • 期刊:
  • 影响因子:
  • 作者:
    Valerie Romoser;Rebecca Ball;Alan V. Smrcka
  • 通讯作者:
    Alan V. Smrcka
Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening
通过基因组规模 CRISPR 筛选对细胞 Lp(a) 摄取进行功能询问
  • DOI:
    10.1101/2024.05.11.593568
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    T. Khan;Juliana Bragazzi Cunha;Chinmay Raut;Michael Burroughs;Sascha N Goonewardena;Alan V. Smrcka;Elizabeth K. Speliotes;Brian T. Emmer
  • 通讯作者:
    Brian T. Emmer

Alan V. Smrcka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alan V. Smrcka', 18)}}的其他基金

Understanding and Manipulating Phospholipase C and G Protein beta gamma subunit Signaling Networks
了解和操作磷脂酶 C 和 G 蛋白 β γ 亚基信号网络
  • 批准号:
    9922940
  • 财政年份:
    2018
  • 资助金额:
    $ 53.64万
  • 项目类别:
Understanding and Manipulating Phospholipase C and G Protein beta gamma subunit Signaling Networks
了解和操作磷脂酶 C 和 G 蛋白 β γ 亚基信号网络
  • 批准号:
    10391472
  • 财政年份:
    2018
  • 资助金额:
    $ 53.64万
  • 项目类别:
2015 Molecular Pharmacology Gordon Research Conference/Gordon Research Seminar
2015年分子药理学戈登研究会议/戈登研究研讨会
  • 批准号:
    8836740
  • 财政年份:
    2015
  • 资助金额:
    $ 53.64万
  • 项目类别:
Phosphatidylinositol 4-Phosphate Hydrolysis in Spatiotemporal Cell Signaling
时空细胞信号传导中的磷脂酰肌醇 4-磷酸水解
  • 批准号:
    9420176
  • 财政年份:
    2014
  • 资助金额:
    $ 53.64万
  • 项目类别:
Phosphatidylinositol 4-phosphate Hydrolysis in Spatiotemporal Cell Signaling
时空细胞信号转导中的磷脂酰肌醇 4-磷酸水解
  • 批准号:
    8756479
  • 财政年份:
    2014
  • 资助金额:
    $ 53.64万
  • 项目类别:
Phosphatidylinositol 4-phosphate Hydrolysis in Spatiotemporal Cell Signaling
时空细胞信号转导中的磷脂酰肌醇 4-磷酸水解
  • 批准号:
    8911848
  • 财政年份:
    2014
  • 资助金额:
    $ 53.64万
  • 项目类别:
Selective Targeting of G Protein beta gamma Subunits with Small Molecules
小分子选择性靶向 G 蛋白 β γ 亚基
  • 批准号:
    8051989
  • 财政年份:
    2010
  • 资助金额:
    $ 53.64万
  • 项目类别:
Selective Targeting of G Protein beta gamma Subunits with Small Molecules
小分子选择性靶向 G 蛋白 β γ 亚基
  • 批准号:
    9321302
  • 财政年份:
    2008
  • 资助金额:
    $ 53.64万
  • 项目类别:
Selective Targeting of G Protein beta gamma Subunits with Small Molecules
小分子选择性靶向 G 蛋白 β γ 亚基
  • 批准号:
    8846612
  • 财政年份:
    2008
  • 资助金额:
    $ 53.64万
  • 项目类别:
Selective Targeting of G Protein beta gamma Subunits with Small Molecules
小分子选择性靶向 G 蛋白 β γ 亚基
  • 批准号:
    7755402
  • 财政年份:
    2008
  • 资助金额:
    $ 53.64万
  • 项目类别:

相似海外基金

Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8358448
  • 财政年份:
    2012
  • 资助金额:
    $ 53.64万
  • 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
  • 批准号:
    8517552
  • 财政年份:
    2012
  • 资助金额:
    $ 53.64万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7952159
  • 财政年份:
    2009
  • 资助金额:
    $ 53.64万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7952152
  • 财政年份:
    2009
  • 资助金额:
    $ 53.64万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7719194
  • 财政年份:
    2008
  • 资助金额:
    $ 53.64万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7605416
  • 财政年份:
    2007
  • 资助金额:
    $ 53.64万
  • 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
  • 批准号:
    7605425
  • 财政年份:
    2007
  • 资助金额:
    $ 53.64万
  • 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
  • 批准号:
    7378753
  • 财政年份:
    2006
  • 资助金额:
    $ 53.64万
  • 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
  • 批准号:
    6825160
  • 财政年份:
    2004
  • 资助金额:
    $ 53.64万
  • 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
  • 批准号:
    2702283
  • 财政年份:
    1997
  • 资助金额:
    $ 53.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了